Clinical Trials
5
Active:0
Completed:2
Trial Phases
2 Phases
Phase 2:1
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (66.7%)Phase 2
1 (33.3%)Carillon Mitral Contour System for Treatment of Exercise Induced Functional Mitral Regurgitation
Withdrawn
- Conditions
- Mitral Regurgitation
- First Posted Date
- 2021-09-10
- Last Posted Date
- 2022-10-07
- Lead Sponsor
- Cardiac Dimensions Pty Ltd
- Registration Number
- NCT05040451
An Initial Evaluation of the Carillon Mitral Contour System for Treatment of Atrial Function Mitral Regurgitation
Not Applicable
Terminated
- Conditions
- Atrial FibrillationAtrial Functional Mitral RegurgitationFunctional Mitral Regurgitation
- First Posted Date
- 2020-08-28
- Last Posted Date
- 2023-03-17
- Lead Sponsor
- Cardiac Dimensions Pty Ltd
- Target Recruit Count
- 4
- Registration Number
- NCT04529928
- Locations
- 🇦🇺
Royal Prince Alfred, Sydney, New South Wales, Australia
🇬🇷European Interbalkan Medical Center, Thessaloníki, Greece
Carillon Mitral Contour System® for Reducing Functional Mitral Regurgitation
Not Applicable
Completed
- Conditions
- Mitral Valve InsufficiencyHeart Failure
- First Posted Date
- 2014-12-25
- Last Posted Date
- 2024-08-05
- Lead Sponsor
- Cardiac Dimensions Pty Ltd
- Target Recruit Count
- 163
- Registration Number
- NCT02325830
- Locations
- 🇦🇺
Royal North Shore Hospital, St. Leonards, New South Wales, Australia
🇦🇺Royal Prince Alfred, Sydney, New South Wales, Australia
🇦🇺Flinders Medical Centre, Adelaide, South Australia, Australia
News
No news found